SEATTLE, July 26, 2021, (MEDGADGET) — Global Nasal Lacrimal Stent Market Analysis
A nasolacrimal stent is a thin tube that is used to treat diseases such as epiphora, as well as congenital nasolacrimal obstruction and DCR (dacryocystorhinostomy). The demand for nasal lacrimal stents is expected to increase as the incidence of NLDO (nasolacrimal duct obstruction), a common lacrimal system syndrome, rises. As per data reported by the National Center for Biotechnology Information (NCBI) in 2019, the prevalence of nasolacrimal duct obstruction in infants’ worldwide range from 6% to 20%.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/3183
Due to the ongoing studies on drugs to treat Epiphora and Dacryocystorhinostomy disease disorders, the nasal lacrimal stent market is expected to grow over the forecast period. The University of Michigan’s Alon Kahana funded a report in October 2019 to assess the effectiveness and effectiveness of the slit stent ii lacrimal stent for the treatment of nasolacrimal duct obstruction.
In addition, the availability of specialized products is projected to propel growth of the global nasal lacrimal stent market. Nunchaku and BIKA intubation systems, a bicanalicular stent used to drain tears through capillary, are among the drugs offered by FCI Ophthalmic.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3183
The lack of alternative treatments for epiphora medical problems is a big restraint on the demand for nasal lacrimal stents. The majority of pharmaceutical firms are concentrating their efforts on producing promising treatments for the treatment of ophthalmic diseases.
During the forecast period, North America is projected to maintain a leading role in the global nasal lacrimal stent market, as key market players concentrate on expanding their footprint in the field. FCI Ophthalmics and Carl Zeiss Canada Ltd. signed an agreement in January 2019 to distribute FCI Ophthalmics’ lacrimal stents and tubes in Canada, including Bika & Nunchaku, Crawford & Ritleng, and Mini Monoka & new Masterka.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/3183
Major companies contributing in the global nasal lacrimal stent market are Kaneka Corporation, Sinopsys Surgical, Inc., FCI Ophthalmics, and Cook Medical LLC.
Nasal Lacrimal Stent Market- Taxonomy
The nasal lacrimal stent market is segmented on the basis of product type, application, end-user, and region
By Product Type
- Bicanalicular Stents
- Monocanalicular Stents
- Dacryocystorhinostomy (DCR)
- Congenital nasolacrimal obstruction
- Ophthalmic Surgery Centers
- North America
- Latin America
- Asia Pacific
- Middle East
Table of Content
Global Nasal Lacrimal Stent Market Research Report
Section 1: Global Nasal Lacrimal Stent Industry Overview
Section 2: Global Economic Impact on Nasal Lacrimal Stent Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Nasal Lacrimal Stent Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Nasal Lacrimal Stent Market Forecast
Other Exclusive Reports:
Vascular Grafts Market, By Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Bypass Graft, Peripheral Vascular Graft, Others), By Application (Coronary Artery Disease, Vascular Occlusion, Renal Failure, Aneurysm, Others), By Material (Synthetic (Teflon, Nylon, Dacron, Others), Biological, Biosynthetic, By End User (Hospitals, Ambulatory Surgical Centers, Others) – Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2018-2026
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027